Enzoduce-D Tablet is a combination pharmaceutical formulation containing Bromelain (90 mg), Diclofenac (50 mg), Rutoside (100 mg), and Trypsin Chymotrypsin (48 mg), designed to provide effective anti-inflammatory, analgesic, and fibrinolytic effects. Bromelain, a proteolytic enzyme derived from pineapple stems, aids in reducing inflammation and edema by modulating the inflammatory response. Diclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts potent analgesic and anti-inflammatory actions by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Rutoside, a bioflavonoid, enhances capillary strength and reduces vascular permeability, contributing to decreased tissue edema and improved microcirculation. Trypsin and Chymotrypsin are proteolytic enzymes that facilitate the breakdown of protein-based exudates and necrotic tissue, promoting faster resolution of inflammation and tissue repair. The synergistic action of these components makes Enzoduce-D effective in managing acute and chronic inflammatory conditions such as musculoskeletal injuries, postoperative inflammation, and soft tissue trauma. It is indicated for pain relief, reduction of swelling, and enhancement of healing processes. Enzoduce-D should be used under medical supervision, with attention to contraindications related to NSAID use and enzyme hypersensitivity.